HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 49 filers reported holding HARPOON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $66,000 | -59.0% | 68,115 | -19.1% | 0.00% | – |
| Q2 2022 | $161,000 | -68.6% | 84,234 | -18.4% | 0.00% | – |
| Q1 2022 | $513,000 | -1.2% | 103,267 | +50.3% | 0.00% | – |
| Q4 2021 | $519,000 | -3.2% | 68,689 | +1.2% | 0.00% | – |
| Q3 2021 | $536,000 | -59.1% | 67,871 | -28.2% | 0.00% | – |
| Q2 2021 | $1,310,000 | +113.0% | 94,484 | +221.5% | 0.00% | – |
| Q1 2021 | $615,000 | +20.6% | 29,387 | -4.2% | 0.00% | – |
| Q4 2020 | $510,000 | -4.1% | 30,687 | -2.2% | 0.00% | – |
| Q3 2020 | $532,000 | +50.3% | 31,380 | +46.9% | 0.00% | – |
| Q2 2020 | $354,000 | – | 21,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
| MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
| Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
| EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
| Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
| Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
| Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
| Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |